178 related articles for article (PubMed ID: 12393642)
1. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.
Decker T; Hipp S; Ringshausen I; Bogner C; Oelsner M; Schneller F; Peschel C
Blood; 2003 Jan; 101(1):278-85. PubMed ID: 12393642
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
4. Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways.
Bogner C; Schneller F; Hipp S; Ringshausen I; Peschel C; Decker T
Exp Hematol; 2003 Mar; 31(3):218-25. PubMed ID: 12644019
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
[TBL] [Abstract][Full Text] [Related]
7. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
Lu M; Kwan T; Yu C; Chen F; Freedman B; Schafer JM; Lee EJ; Jameson JL; Jordan VC; Cryns VL
J Biol Chem; 2005 Feb; 280(8):6742-51. PubMed ID: 15569667
[TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
10. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Wang P; Pavletic ZS; Joshi SS
Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells.
Ringshausen I; Oelsner M; Bogner C; Peschel C; Decker T
Leukemia; 2008 Mar; 22(3):635-8. PubMed ID: 17805332
[No Abstract] [Full Text] [Related]
12. Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target.
Decker T; Hipp S; Hahntow I; Schneller F; Peschel C
Br J Haematol; 2004 Apr; 125(2):141-8. PubMed ID: 15059135
[TBL] [Abstract][Full Text] [Related]
13. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone.
Strömberg T; Dimberg A; Hammarberg A; Carlson K; Osterborg A; Nilsson K; Jernberg-Wiklund H
Blood; 2004 Apr; 103(8):3138-47. PubMed ID: 15070696
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.
García-Morales P; Hernando E; Carrasco-García E; Menéndez-Gutierrez MP; Saceda M; Martínez-Lacaci I
Mol Cancer Ther; 2006 Sep; 5(9):2172-81. PubMed ID: 16985050
[TBL] [Abstract][Full Text] [Related]
17. Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes.
Hleb M; Murphy S; Wagner EF; Hanna NN; Sharma N; Park J; Li XC; Strom TB; Padbury JF; Tseng YT; Sharma S
J Biol Chem; 2004 Jul; 279(30):31948-55. PubMed ID: 15131122
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
19. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.
Anandharaj A; Cinghu S; Park WY
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):292-300. PubMed ID: 21367753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
